Cancer in men: BRCA2 mutations ‘more important’ than BRCA1
Results from international study might help guide screening, researchers say
Men with germline BRCA2 pathogenic variants are more at risk of cancer than those with BRCA1 mutations, a study shows.
International researchers examined data on more than 6900 men, of whom 3651 carried BRCA1 and 3251, BRCA2, pathogenic variants.
